Grandchamp B, Picat C, de Rooij F, Beaumont C, Wilson P, Deybach J C, Nordmann Y
Laboratoire de Génétique Moléculaire, Faculté de Médecine X.Bichat, Paris, France.
Nucleic Acids Res. 1989 Aug 25;17(16):6637-49. doi: 10.1093/nar/17.16.6637.
We have determined the mutation in a patient with acute intermittent porphyria. The mRNA coding for porphobilinogen deaminase was reverse transcribed then the cDNA was enzymatically amplified in vitro. Upon sequencing of a polymerase chain reaction product of abnormal size we found that this fragment lacked exon 12 of the gene. We analysed a genomic fragment containing exon 12 and determined that the patient was heterozygous for a point mutation G A at the last position of exon 12. We propose that this base change is responsible for an abnormal processing of the mutant allele such that exon 12 is missing in the mature mRNA. The resulting aberrant mRNA encodes a truncated protein which is inactive but stable and can be detected using antibodies directed against the normal enzyme.
我们已确定一名急性间歇性卟啉症患者的突变情况。编码胆色素原脱氨酶的信使核糖核酸(mRNA)被反转录,然后互补脱氧核糖核酸(cDNA)在体外进行酶促扩增。对异常大小的聚合酶链反应产物进行测序时,我们发现该片段缺少该基因的第12外显子。我们分析了一个包含第12外显子的基因组片段,确定该患者在第12外显子最后一位存在G→A的点突变,为杂合子。我们认为这种碱基变化导致突变等位基因的异常加工,使得成熟mRNA中缺少第12外显子。由此产生的异常mRNA编码一种截短的蛋白质,该蛋白质无活性但稳定,可用针对正常酶的抗体检测到。